In this episode, we will discuss some of the interesting and unusual warfarin interactions such as acetaminophen, alcohol, agents with antiplatelet properties, non-green vitamin K foods, and CBD/THC.

In this episode, we discuss the pathophysiology, drug-related causes, diagnosis, and treatment of a common type of hyponatremia called the syndrome of inappropriate antidiuretic hormone (SIADH).

In this episode, we discuss the latest dyslipidemia treatment agent bempedoic acid and dive into its pharmacology, use, and clinical evidence.

In this episode, we discuss the proposed risks of using beta blockers in patients with cocaine use disorders and whether evidence supports this drug interaction as an “absolute” contraindication.

In this episode, we dive into the pharmacology of ACE inhibitors and ARBs, particularly understanding how they assist in preserving renal function in CKD and yet at the same time can harm the kidneys (e.g. cause AKI).

In this episode, we partner with Dr. Danielle Candelario and Dr. Sneha Srivastava, clinical skills faculty at our college, to discuss tips, tricks, and common pitfalls to avoid when performing medication counseling.

In this episode, we discuss the historical significance of Staphylococcus aureus including its patterns of antimicrobial resistance and recommended treatments.

In this episode, we discuss important nutritional deficiencies as well as pharmacologic changes that occur in post-bariatric surgery patients.

In this episode, we review ten clinical pearls about total parenteral nutrition (TPN) that all pharmacists should know.

In this episode, we will discuss the most recent evidence for the use of omega-3 fatty acids (fish oil) for ASCVD risk reduction.